Vonova

Vonova is a United States medical device company based in San Diego, California. According to its official website, the company is focused on transforming access to the brain without drilling through the skull. Its stated mission is to unlock access to the treatment of chronic neurological disorders using minimally invasive transvascular technology. The company frames its work around a clinical problem: reaching the brain surface currently requires invasive skull drilling, which carries risks of infection, brain injury, and long recovery, and which limits access to care for millions of patients with chronic neurological disorders. Vonova identifies chronic subdural hematomas, neuropathic pain, and epilepsy as target conditions where a less invasive and more efficient method of delivering diagnostic and therapeutic treatments to the brain surface is critically needed. Vonova's proposed solution leverages the body's venous system as a natural pathway to the brain. The approach is described as minimally invasive and non-surgical, enabling intracranial access without the risk and invasiveness of drilling through the skull. By avoiding open cranial procedures, the company aims to reduce procedure-related risks and costs that deter patients and burden healthcare systems. As of the available evidence, Vonova is an early-stage or privately held company; no public listing, parent company, or ownership structure is disclosed in the supplied sources. Its public presence centers on its official website, which presents the mission, the clinical problem, and the transvascular solution. The company is associated with San Diego, a recognized hub for life sciences and medical device innovation.

Vonova is a medical device company located in San Diego, California, in the United States. Public information about the company is limited and centers on its official website and a Wikidata entry identifying it as a company in San Diego. The company's public narrative is built around a specific clinical and technological thesis: that access to the brain should not require drilling through the skull. Vonova states that its mission is to unlock access to the treatment of chronic neurological disorders using minimally invasive transvascular technology. This positions the company within the broader field of neurointerventional and minimally invasive medical devices, where clinicians and developers seek to reach intracranial targets through natural pathways such as the vascular system rather than through open surgical approaches. According to its website, Vonova identifies a critical unmet need: current treatments for conditions such as chronic subdural hematomas, neuropathic pain, and epilepsy involve invasive skull drilling, which risks infection, brain injury, and long recovery. The company argues that these procedures and their costs deter patients and burden healthcare systems, limiting access to care for millions of patients with chronic neurological disorders. Vonova's proposed solution is to leverage the body's venous system as a natural pathway to the brain. The company describes this approach as minimally invasive and non-surgical, enabling intracranial access without the risk and invasiveness of drilling through the skull. The stated goal is to deliver diagnostic and therapeutic treatments to the brain surface more efficiently and with less risk. As of the available evidence, no founding date, founder names, funding history, regulatory milestones, or product approvals are disclosed. The company appears to be privately held, with no parent company or ownership information provided in the supplied sources. Its headquarters location in San Diego places it within a major regional cluster for biotechnology and medical device development.

Minimally invasive, non-surgical transvascular access to the brain as an alternative to invasive skull drilling for chronic neurological disorders.

• Transvascular brain access technology

  A minimally invasive, non-surgical platform that uses the body's venous system as a natural pathway to reach the brain surface, intended for diagnostic and therapeutic treatments for chronic neurological disorders such as chronic subdural hematomas, neuropathic pain, and epilepsy.

1. 1Vonovavonova.io
2. 2Vonova (United States) - Wikidatawikidata.org